ENTR-601-44 clinical trials

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

This study looks at a new medicine, ENTR-601-44, for Duchenne muscular dystrophy (DMD). We want to see if it's safe, what side effects it might have, and if it helps people with DMD. It involves regular check-ups and is for males aged 4-20.